| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Integrative Physiology |
From the Division of Cardiology (H.L.P., M.A.K., M.L., M.S., K.T.K., D.J.S.), Keenan Research Centre in the Li Ka Shing Knowledge Institute, St Michaels Hospital, Toronto, Ontario, Canada; the Cardiovascular Division (J.R.L.), Oregon Health and Science University, Portland; and the University of Virginia (A.L.K.), Charlottesville.
Correspondence to Howard Leong-Poi, MD, 7-052 Bond Wing, St Michaels Hospital, 30 Bond Street, Toronto, Ontario, Canada M5B 1W8. E-mail leong-poih{at}smh.toronto.on.ca
Current methods of gene delivery for therapeutic angiogenesis are invasive, requiring either intraarterial or intramuscular administration. A noninvasive method of gene delivery has been developed using ultrasound-mediated destruction of intravenously administered DNA-bearing carrier microbubbles during their microcirculatory transit. Here we show that chronic ischemia could be markedly improved by ultrasound-mediated destruction of microbubbles bearing vascular endothelial growth factor-165 (VEGF165) plasmid DNA. Using a model of severe chronic hindlimb ischemia in rats, we demonstrated that ultrasound mediated VEGF165/green fluorescent protein (GFP) plasmid delivery resulted in a significant improvement in microvascular blood flow by contrast-enhanced ultrasound, and an increased vessel density by fluorescent microangiography, with minimal changes in control groups. The improvement in tissue perfusion was attributed predominantly to increases in noncapillary blood volume or arteriogenesis, with perfusion peaking at 14 days after delivery, followed by a partial regression of neovascularization at 6 weeks. Transfection was localized predominantly to the vascular endothelium of arterioles in treated ischemic muscle. RT-PCR confirmed the presence of VEGF165/GFP mRNA within treated ischemic muscle, being highest at day 3 postdelivery, and subsequently decreasing, becoming almost undetectable by 6 weeks. We found a modulation of endogenous growth factor expression in VEGF-treated ischemic muscle, consistent with a biologic effect of ultrasound mediated gene delivery. The results of our study demonstrate the utility of ultrasonic destruction of plasmid-bearing microbubbles to induce therapeutic arteriogenesis in the setting of severe chronic ischemia.
Key Words: angiogenesis gene therapy contrast ultrasound peripheral vascular disease chronic ischemia
Related Article:
Circ. Res. 2007 101: 232-233.
This article has been cited by other articles:
![]() |
J. Kobulnik, M. A. Kuliszewski, D. J. Stewart, J. R. Lindner, and H. Leong-Poi Comparison of gene delivery techniques for therapeutic angiogenesis ultrasound-mediated destruction of carrier microbubbles versus direct intramuscular injection. J. Am. Coll. Cardiol., October 27, 2009; 54(18): 1735 - 1742. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gupta, J. Tongers, and D. W. Losordo Human Studies of Angiogenic Gene Therapy Circ. Res., October 9, 2009; 105(8): 724 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. S. Villanueva Ultrasound Mediated Destruction of DNA-Loaded Microbubbles for Enhancement of Cell-Based Therapies: New Promise Amidst a Confluence of Uncertainties? J. Am. Coll. Cardiol. Img., July 1, 2009; 2(7): 880 - 882. [Full Text] [PDF] |
||||
![]() |
B. D.M. Meijering, L. J.M. Juffermans, A. van Wamel, R. H. Henning, I. S. Zuhorn, M. Emmer, A. M.G. Versteilen, W. J. Paulus, W. H. van Gilst, K. Kooiman, et al. Ultrasound and Microbubble-Targeted Delivery of Macromolecules Is Regulated by Induction of Endocytosis and Pore Formation Circ. Res., March 13, 2009; 104(5): 679 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. van Oostrom, O. van Oostrom, P. H. A. Quax, M. C. Verhaar, and I. E. Hoefer Insights into mechanisms behind arteriogenesis: what does the future hold? J. Leukoc. Biol., December 1, 2008; 84(6): 1379 - 1391. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Modarai, J. Humphries, J.A. Gossage, M. Waltham, K.G. Burnand, G.S. Kanaganayagam, A. Afuwape, E. Paleolog, A. Smith, and A. Wadoodi Adenovirus-Mediated VEGF Gene Therapy Enhances Venous Thrombus Recanalization and Resolution Arterioscler Thromb Vasc Biol, October 1, 2008; 28(10): 1753 - 1759. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Chappell, J. Song, A. L. Klibanov, and R. J. Price Ultrasonic Microbubble Destruction Stimulates Therapeutic Arteriogenesis Via the CD18-Dependent Recruitment of Bone Marrow-Derived Cells Arterioscler Thromb Vasc Biol, June 1, 2008; 28(6): 1117 - 1122. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. T. Rissanen, P. Korpisalo, H. Karvinen, T. Liimatainen, S. Laidinen, O. H. Grohn, and S. Yla-Herttuala High-resolution ultrasound perfusion imaging of therapeutic angiogenesis. J. Am. Coll. Cardiol. Img., January 1, 2008; 1(1): 83 - 91. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takahashi and H. Matsubara New Targeted Angiogenic Strategy: Bursting Bubbles Circ. Res., August 3, 2007; 101(3): 232 - 233. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |